By Tyler Durden – Zero Hedge – 11/11/2020
On Monday, Pfizer shares soared 16% following a bullish statement on the company’s experimental COVID-19 vaccine showed 90% effectiveness in preliminary results. Then on Tuesday, according to a Securities and Exchange Commission filing, Pfizer CEO Albert Bourla sold 62% of his stock.
Pfizer’s CEO Dumps 62% Of His Stock On COVID Vaccine Announcement
Tag: nCoV
THE WAR IS OVER … GLOBOCAP TRIUMPHS!
Oxford epidemiologist PROFESSOR SUNETRA GUPTA tells how she has been intimidated and shamed for backing shielding instead of lockdown
Pfizer, BioNTech say vaccine 90% effective; Biden picks Covid task force
Designing digital immunity certificates for COVID-19
Companies are preparing to design digital immunity certificates for COVID-19 that could be used when a vaccine is available.
Ailments in Covid-19 Trials Raise Questions About Vaccine Method
Ailments in Covid-19 Trials Raise Questions About Vaccine Method
“While it could be a coincidence,” said Sam Fazeli, a Bloomberg Intelligence analyst, in a research note, “there’s still the possibility that adenoviral vector vaccines run a higher risk of rare side effects — such as autoimmune attacks like transverse myelitis — than those of Pfizer-BioNTech, Moderna or Novavax.”
Ms. Cat’s Chronicles 
You must be logged in to post a comment.